J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lakshmi, V.
Right arrow Articles by Dandona, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lakshmi, V.
Right arrow Articles by Dandona, L.
Agricola
Right arrow Articles by Lakshmi, V.
Right arrow Articles by Dandona, L.
J Med Microbiol 58 (2009), 312-317; DOI: 10.1099/jmm.0.005249-0
© 2009 Society for General Microbiology
ISSN 0022-2615

Application of human immunodeficiency virus type 1 BED enzyme immunoassay on dried blood spots in India

Vemu Lakshmi1, Talasila Sudha1, Rakhi Dandona2,3,4, Vijay D. Teja1, G. Anil Kumar2,3 and Lalit Dandona2,3,4

1 Department of Microbiology, Nizam's Institute of Medical Sciences, Hyderabad, India

2 George Institute for International Health – India, Hyderabad, India

3 Health Studies Area, Administrative Staff College of India, Hyderabad, India

4 School of Public Health and George Institute for International Health, University of Sydney, Sydney, Australia

Correspondence
Vemu Lakshmi
lgorthi{at}hotmail.com

Received July 21, 2008
Accepted November 12, 2008

Dried blood spots (DBSs) on filter paper are being used increasingly in population-based human immunodeficiency virus (HIV) studies. This study evaluated the application of a BED enzyme immunoassay (EIA) on DBSs to estimate HIV incidence in a population-based study in India. The Calypte HIV-1 BED Incidence EIA was performed on 224 HIV-1-positive DBS samples, after screening 12 617 individuals from a population-based sample in Guntur district in the southern Indian state of Andhra Pradesh. The number of recently infected HIV cases was identified using this BED assay and was used to estimate the annual HIV incidence rate based on calculations and adjustment formulae suggested by the Centers for Disease Control and Prevention (CDC). The updated BED data management software provided by the CDC was used for analyses. Of the 224 HIV-1 antibody-positive DBS samples, 29 (12.95 %) were estimated by the BED HIV-1 assay to have been infected within the past 155 days. After adjusting for age, gender and rural/urban distribution of the population, the annual incidence rate of HIV-1 infection was estimated to be 0.32 % (95 % confidence interval 0.20–0.44 %). This annual incidence was 18.6 % of the HIV prevalence of 1.72 % in this study. Thus, the BED assay revealed a higher incidence of HIV in this study than was expected from the prevalence. Correlation of the BED assay with panel testing and longitudinal incidence data in the Indian population is needed to calibrate it for use in India.

Abbreviations: An, normalized absorbance value; BED-CEIA, peptide-based BED capture enzyme immunoassay; CAL, calibrator; CDC, Centers for Disease Control and Prevention; CI, confidence interval; DBS, dried blood spot; EIA, enzyme immunoassay; HIV, human immunodeficiency virus; HPC, high positive control; LPC, low positive control; QA, quality assurance.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2009 Society for General Microbiology.